Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesHemostasis, Inflammation, and Fatal and Nonfatal Coronary Heart Disease. Long-Term Follow-Up of the Atherosclerosis Risk in Communities (ARIC) Cohort
Arteriosclerosis, Thrombosis, and Vascular Biology, 10/26/09
Kucharska–Newton AM et al. – Von Willebrand factor and factor VIIIc are associated with an increased risk of cardiac death as compared to the risk of nonfatal MI.
Related Articles
Screening for Subclinical Coronary Artery Disease Measuring Carotid Intima Media Thickness
The American Journal of Cardiology, 11/10/09
Relevance Score: 83%
Prognostic significance of left ventricular mass by magnetic resonance imaging study in patients with known or suspected coronary artery disease
Journal of Hypertension, 10/28/09
Relevance Score: 83%
Prognostic value of myocardial metabolic imaging with BMIPP in the spectrum of coronary artery disease: A systematic review
Journal of Nuclear Cardiology, 10/28/09
Relevance Score: 83%
Coronary Artery Disease in Patients With Peripheral Artery Disease
Heart & Lung; The Journal of Acute and Critical Care, 10/27/09
Relevance Score: 83%
Coronary artery disease threatens millions, but early diagnosis, treatment can reduce risk
Internet Source, 10/06/09
Relevance Score: 83%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Hyperlipidemia in Older Adults
Clinics in Geriatric Medicine, 12/01/09
Life Course Socioeconomic Conditions and Metabolic Syndrome in Adults: The Atherosclerosis Risk in Communities (ARIC) Study
Annals of Epidemiology , 12/01/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09
Sponsor
Article Search
Sponsor